Gupta Shalabh K. 4
4 · Unicycive Therapeutics, Inc. · Filed Apr 17, 2024
Insider Transaction Report
Form 4
Gupta Shalabh K.
DirectorCEO
Transactions
- Award
Stock Options
2024-04-15+1,319,583→ 6,206,637 totalExercise: $1.14Exp: 2034-04-15→ Common Stock (1,319,583 underlying)
Footnotes (1)
- [F1]329,896 of the stock options vest on the first anniversary of the date of grant and 1/36th of the remaining options vest at the end of each successive month thereafter.